Skip to main content

Advertisement

Table 2 Hazard ratios of mortality according to baseline variables in HBV-infected patients starting antiviral treatment in Ethiopia (n = 276)

From: Predictors of mortality in patients under treatment for chronic hepatitis B in Ethiopia: a prospective cohort study

Baseline variables Unadjusted P Adjusted P
HR (95% CI) HR (95% CI)
Sex (male vs. female) 1.44 (0.60–3.48) 0.413
Age (years) 1.03 (1.00–1.06) 0.106 1.06 (1.02–1.10) 0.007
ALT (≥80 U/L vs. < 80 U/L) 1.19 (0.46–3.06) 0.722
BMI (< 18.5 kg/m2 vs. > 18.5 kg/m2) 2.84 (1.43–5.62) 0.003 3.65 (1.73–7.72) 0.001
Transient elastography (kPa)
  < 8.0 1   N/D a  
  8.0–9.9 1.29 (0.08–20.57) 0.859  
  ≥ 10.0 9.06 (1.24–66.43) 0.030
Cirrhosis assessment
 No cirrhosis 1   1  
 Compensated cirrhosis 1.12 (0.07–17.95) 0.935 0.89 (0.06–14.42) 0.937
 Decompensated cirrhosis 28.10 (3.84–205.51) 0.001 23.68 (3.23–173.48) 0.002
  1. aTransient elastography could not be included in the adjusted model because of a strong correlation with one of the other variables
  2. HR hazard ratio, CI confidence interval, ALT alanine aminotransferase, BMI body mass index